LRCG in the News
The ASCO Post: Professor Anthony Moorman on ALL June 2020
Professor Anthony Moorman presents 'Improved outcome for ABL-class patients with ALL when treated with TKI' as part of the European Hematology Association Virtual Congress 2020 (The ASCO Post)
Last modified: Tue, 11 Aug 2020 10:24:00 BST
ecancer: Professor Anthony Moorman on ALL December 2019
Professor Anthony Moorman speaks to ecancer at the 2019 ASH meeting in Orlando about a study looking at the prognostic impact of chromosomal abnormalities and copy number alterations in B-cell precursor ALL treated on UKALL14.
Last modified: Tue, 14 Jan 2020 11:59:07 GMT
Bloodwise: Hugo and Henry's Virtual Tour of the LRCG Laboratory May 2019
Bloodwise captured the moment Professor Christine Harrison took Hugo and his brother Henry on a virtual tour of the LRCG laboratory and met the blood cancer researchers whose crucial work spared him from the most gruelling treatment.
Last modified: Thu, 21 Nov 2019 11:55:42 GMT
Leukaemia Care: Professor Anthony Moorman on ALL June 2018
Professor Anthony Moorman talks to Leukaemia Care about what ALL is.
Last modified: Thu, 21 Nov 2019 11:49:23 GMT
Bloodwise: Professor Christine Harrison on Childhood Leukaemia October 2017
Professor Christine Harrison describes new treatments in development which target leukaemia cells to give children with leukaemia a better quality of life
Last modified: Thu, 21 Nov 2019 10:03:58 GMT
.jpg)
